GlassScriptPhysician profile
Robert Thomas Wicks
NPI 1881985323
$5,859.16
in general payments reported to CMS, 2019-2025
19 companies · $638 in 2025
The $638 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $39.64 · 2021: $465 · 2022: $2,162 · 2023: $560 · 2024: $1,652 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,915 · Travel and Lodging: $935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,914.75 |
| Travel and Lodging | $935.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,961.45 | 2022-2025 | Evolve, Surpass Evolve, Target |
| Microvention, INC. | $1,700.29 | 2022-2025 | Stent, Tubing Kit - Stroke, Web Aneurysm Embolization System |
| Imperative Care, INC | $526.91 | 2023-2025 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter |
| Medtronic, INC. | $422.82 | 2021-2025 | Pipeline, Kyphon Express II Kyphopak Tray |
| Penumbra, INC. | $279.98 | 2021-2022 | |
| Depuy Synthes Sales INC. | $266.68 | 2019-2024 | Trufill |
| Viz.Ai, INC. | $122.37 | 2022 | |
| Aesculap, INC. | $115.13 | 2019 | |
| Carl Zeiss Meditec, INC. | $109.82 | 2019 | |
| Route 92 Medical, INC. | $75.52 | 2022 | |
| Mizuho America, INC. | $69.65 | 2023-2024 | |
| Dynasplint Systems INC. | $34.42 | 2022 | |
| Irras USA, INC. | $31.10 | 2023 | |
| Omniscient Neurotechnology America LTD | $30.22 | 2023 | Quicktome |
| Integra Lifesciences Corporation | $28.82 | 2023 | Duraseal Exact Spinal Sealant System, Codman Hakim, Cusa Clarity |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $25.00 | 2025 | Wainua |
| Boston Scientific Corporation | $24.02 | 2024 | Vercise |
| Inspiremd LTD | $20.00 | 2025 | Cguard Prime Carotid Stent System |
| Insightec,INC | $14.96 | 2024 | Exablate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.